Kevin White

Company: Abbvie

Job title: Director

Seminars:

Panel Discussion: Evaluating Antigen-Specific vs Antigen-Non-Specific Approaches: Assessing ‘Tolerance’ to Benchmark Tolerizing Strategies 11:00 am

Reviewing what we mean by ‘tolerance’ in autoimmune diseases to understand the end goal and refine biomarker, preclinical model, dosage, and delivery considerations Discussing antigen-non-specific or antigen-agnostic approaches Debating the possibilities of antigen-specific approaches for autoimmune diseases by looking cross-field to both allergy and transplant successesRead more

day: Conference Day One